Flarin: Funding, Investors & Team (Oct 2026)
Flarin is the sole OTC medication containing lipid-formulated ibuprofen 200mg, specifically designed to alleviate joint pain and inflammation during flare-ups. It is intended for the relief of rheumatic or muscular pain, back pain, and non-serious arthritic conditions characterized by joint swelling, stiffness, and inflammation. Clinical evidence has shown that Flarin is equally effective as prescribed ibuprofen (2400 mg) in reducing joint pain. A recent clinical study, focusing on flare-ups in joints, was conducted in 27 primary care centers with 462 patients and demonstrated the efficacy of combining ibuprofen in a lipid formulation for flare-up control. Flarin is available in packs of 30 and 12 soft capsules and is a patented technology of infirst Ltd. The essential information regarding Flarin includes its dosage as 200mg soft capsules containing ibuprofen, its indication for relief from various types of pain, and a reminder to always read the accompanying leaflet.
Flarin has raised $6.4M across 1 funding round on record, the most recent an undisclosed round of $6.4M announced in Aug 2023.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Flarin Company Profile and Key Stats
Latest funding round on record: Aug 2023.
Flarin Funding Rounds
Flarin Founders and Leadership Team
No contact details are on record for this team yet.
Flarin Funding Compared to Other Health Care Startups
Flarin's latest round of $6.4M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Flarin in Health Care and London
Companies Similar to Flarin
We are pioneering the use of semiconductor technology for next-generation neural implants. Our mission is to…
52 North Health intends to further develop medical services with a clinical gadget that utilizes man-made…
SageTech is recycling inhalational anaesthetic agents using patented technology to generate significant cost…
Renata Medical develops purposeful medical devices for unmet pediatric needs.
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills…
Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous…
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders.…
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial…
Innovative medical gadgets are created by Creo Medical Limited, situated in Chepstow, South Wales. With a…
TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system…
NEX Health Intelligence (NEX) is a health-tech business that develops AI-powered software for hospitals to…
Flarin Funding FAQs
What does Flarin do?
Flarin is the sole OTC medication containing lipid-formulated ibuprofen 200mg, specifically designed to alleviate joint pain and inflammation during flare-ups. It is intended for the relief of rheumatic or muscular pain, back pain, and non-serious arthritic conditions characterized by joint swelling, stiffness, and inflammation. Clinical evidence has shown that Flarin is equally effective as prescribed ibuprofen (2400 mg) in reducing joint pain. A recent clinical study, focusing on flare-ups in joints, was conducted in 27 primary care centers with 462 patients and demonstrated the efficacy of combining ibuprofen in a lipid formulation for flare-up control. Flarin is available in packs of 30 and 12 soft capsules and is a patented technology of infirst Ltd. The essential information regarding Flarin includes its dosage as 200mg soft capsules containing ibuprofen, its indication for relief from various types of pain, and a reminder to always read the accompanying leaflet.
How much funding has Flarin raised?
Flarin has raised $6.4M across 1 round on record. The most recent is an undisclosed round of $6.4M announced in Aug 2023.
When did Flarin last raise funding?
Flarin's most recent funding round on record is an undisclosed round of $6.4M, announced in Aug 2023.
Who founded Flarin?
FundedIQ lists Heli Doshi (Founder) at Flarin.
Where is Flarin headquartered?
Flarin is based in London, England, United Kingdom.
How many employees does Flarin have?
Flarin is in the 1-10 employee band.
How does Flarin's funding compare to other Health Care startups?
Flarin's latest round of $6.4M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Flarin Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Flarin is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.